hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 8.45
-0.25 (-2.87%)
Apr 15, 2026, 5:07 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 57.49 million as of April 15, 2026. Its market cap has decreased by -36.94% in one year.
Market Cap
57.49M
Enterprise Value
48.91M
Revenue
54.47M
Ranking
n/a
PE Ratio
10.99
Stock Price
8.45
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 57.49M, an increase of 233.52%. That is a compound annual growth rate of 19.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 59.19M | 38.10% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 132.32M |
| Bioventix | 96.66M |
| 4basebio | 79.71M |
| Hemogenyx Pharmaceuticals | 61.68M |
| Ondine Biomedical | 57.15M |
| Faron Pharmaceuticals Oy | 52.57M |
| ImmuPharma | 30.67M |
| Poolbeg Pharma | 29.61M |